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Doctor C. P. Rhoads, speaking at Yale Medical 
School this winter, ventured the opinion that current studies 
of host reactions to tumors were providing some of the most 
exciting leads in cancer research. Work at Dr. Rhoads’ 
Sloan-Kettering Institute has shown that transplantation of 
cancer into people afflicted with terminal carcinomatosis will 
yield rapid and progressive growth of the implant while the 
same cancer transplanted into normal people will evoke an 
inflammatory response and subsequent death of the transplant. 
This demonstration of the altered reactivity of the person 
harboring a malignant growth points up the need to study the 
tumor host, his defenses and how they may be altered. The 
emphasis on the study of the host as well as the tumor has 
gained increasing recognition in the field of animal cancer 
research over the last decade. 
THE ENCHANCING EFFECT 
Woglom’s review article, ’’Immunity to Transplant¬ 
able Tumors”, published in 1929 stressed the natural defenses 
to transplantation of tumors and the increased immunity to 
tumors following previous injection of that tumor (57). 
However, as early as 190? Flexner and Jobling had found that 
rats injected with a heated emulsion of rat sarcoma ten days 
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prior to the injection of a live graft of this tumor had a 
greater number of growths and the tumors showed more rapid 
growth as compared to animals who had not received the heated 
emulsion (17). Unheated emulsion failed to reproduce this 
effect. Here, then, was evidence that prior contact with a 
tumor could decrease a rat’s immunity to subsequent contact 
with the same tumor. 
Casey (9,14) showed that prior injection of frozen 
Brown-Pearce rabbit tumor into the testicle, skin, subcutan¬ 
eous tissue or muscle of rabbits changed these animals so 
that subsequent inoculations of live Brown-Pearce tumor gave 
increased number of growths, increased size of growths, 
decreased survival time and increased mortality as compared 
to animals which had not been pretreated. Pretreatment with 
fresh tumor did not elicit this phenomenon which Casey called 
the XYZ effect. The specificity of the XYZ effect was 
demonstrated by the inability of pretreatment with frozen 
Brown-Pearce tumor in mice to enhance the growth of Bashford 
mouse carcinoma (10). An even greater specificity of this 
reaction was revealed when Casey (11) showed that mouse 
sarcoma ISO, anaerobically refrigerated for 14 to 60 days at 
24° Fahrenheit, then minced, emulsified and used for pre¬ 
treatment in mice enhanced the growth of grafts of live Sarcoma 
ISO but had no effect on the growth of grafts of Sarcoma 63 
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or Sarcoma 37. Material prepared from a uterine adenocarcin¬ 
oma of rabbits did not enhance the growth of Brown-Pearce 
tumor (13). Furthermore, injection of 0.3 cubic centimeters 
of a filtrate of fresh Brown-Pearce tumor that had been passed 
through a Berkefeld V filter inhibited the growth of subsequent 
grafts of Brown-Pearce tumor (12). 
Snell, Kaliss and their co-workers have studied 
intensively the effects of pretreatment of animals with 
lyophilized tissue, both normal and malignant. This pretreat¬ 
ment could enhance or inhibit the growth of subsequent live 
tumor transplants and which of the two predominated seemed, 
in large measure, to be determined by specific host strain- 
tumor relationship (49). Tumor 15091A, which grows in 
Strain A mice but not in Strains C57 or Balb C, when given as 
lyophilized pretreatment to the latter two strains induced an 
increase number of takes of subsequent grafts of live 15091A 
tumor. Lyophilized myeloid leukemia C149& used as pretreat¬ 
ment in C57 leaden and C57 black strain mice caused a 50 per 
cent reduction in the number of takes of subsequent live 
C149S grafts (43). Swiss white mice treated with frozen 
Sarcoma 1&0 then injected with viable tumor showed a decreased 
number of takes compared to animals that had not been pretreated 
(53). Kaliss and Snell (23) studied the growth of tumor 
15091A in C57 black and C57 brown mice following pretreatment 
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with lyophilized normal tissue from Strain A mice, lyophilized 
tumor 15091A and lyophilized kidney from Strains C and P. The 





















Tumor 15091A 28/35 5/9 
Strain C 
1. kidney l/l8 - 
Strain P 
1. kidney 0/22 - 
Controls 0/33 0/10 
It was evident that lyophilized normal tissue from 
the natural host of the tumor could alter the resistence of 
a foreign strain to live grafts of that tumor (26). Kaliss 
(24) demonstrated that fresh tumor sediment could act to 
enhance tumor grafts. The enhancing effect of live tumor in 
Kaliss’ system contrasts with the previously noted failure of 
Flexner and Jobling (17) to demonstrate an enhancing effect 
with live tumor. 
The failure of non specific substances to produce 
the enhancing effect was shown by the inability of trypan 
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blue and lyophilized kidney, liver and spleen of the rat, 
hamster and guinea pig to enhance the growth of 15091A tumor 
in C57’s (25,27). Other work, though, showed that normal 
kidney and spleen of C57 B1 mice used as lyophilized pretreat 
ment in rats could enhance the take of a mouse mammary car¬ 
cinoma in the rats although the mouse mammary carcinoma does 
not grow in the C57 Bl’s (47). This suggestion of a species 
specificity is at odds with Casey’s work with mouse sarcoma 
and the report of Kaliss and Snell, previously cited, that 
kidney from Strains C and P did not enhance the growth of 
tumor 15091A. This again points up the danger of generalizing 
beyond the specific host-tumor system being studied. 
The use of cortisone with the pretreatment has 
been reported by Kaliss (33,36). Cortisone did not increase 
the number of takes and there is some suggestion that corti¬ 
sone inhibits tumor graft growth when given in this manner. 
The factors of age at onset of pretreatment and 
time interval between pretreatment and transplantation of 
live tissue has been studied. Kaliss found that pretreatment 
had to start before the live graft was made or, at the very 
latest, the day after the live transplantation (37). The 
effect of pretreatment is evident ten months after its con¬ 
clusion in the mouse (32). Pikovski and Schlesinger (47) 
showed that the most important temporal factor was the age 
of the animal at the time pretreatment was begun. Animals 
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below ten days of age when pretreatment was begun gave con¬ 
sistently the highest number of takes. The time interval 
between pretreatment and the live grafting assumes much 
greater importance when live tissue rather than lyophilized 
tissue is used as pretreatment. If the time interval between 
two subcutaneous inoculations of Sarcoma I in C57B1 mice was 
greater than one month the second graft took while if the 
interval was less than one month the second graft regressed. 
None of the initial grafts grew (35). 
The amount of lyophilized tumor used in the pre¬ 
treatment is one determinate of whether the pretreatment will 
yield enhancement or inhibition. Mammary adenocarcinoma 
Eo771 injected into C3H Jax mice will produce a mortality 
rate of 50 per cent. Use of 50 milligrams of lyophilized 
Eo771 as pretreatment will greatly increase this mortality 
rate while use of .05 milligrams for pretreatment will decrease 
the mortality rate almost to zero. Dosages in between pro¬ 
duce gradations of mortality which are directly proportional 
to the dose (22}30), 
The use of specific antisera to transmit the 
enhancing effect has been elucidated by Kaliss and Molomut. 
In one study C57Bl/6Ks mice were injected with splenic tissue 
from Strain A mice and the serum from these C57fs was injected 
into normal C57Bl/6Ks mice. The latter mice then received 
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transplants of Sarcoma I which is indigenous to Strain A. 
Six of fifteen animals so treated died while fifteen normal 
C57’s received the grafting with no mortality (31). The 
same effect can be produced by antisera to Strain A kidney 
and to tumor 15091A which grows in Strain A (2$). The per 
cent of animals with actively growing tumors after this 
method of pretreatment is much lower than that usually 
obtained after pretreatment with lyophilized tumor (2&). 
The growth of tumors in resistant animals follow¬ 
ing pretreatment of the animals produces a change in the 
tumor, as evidenced by an ability to grow in other normally 
resistent strains which have not been pretreated (34). A 
tumor from an inbred strain will gro*w in all mice of the 
same strain and FI hybrids having that strain as one parent. 
Resistant backcross animals (FI hybrids x resistant animal) 
have takes of between 30 per cent to .002 per cent with the 
tendency toward the lower figures. A tumor that grows in 
C3H's but not in C mice will, after growth in FI’s of these 
two strains, when transplanted into resistant backcross mice 
yield three and one half times (30 per cent vs. eight per cent) 
greater mortality than those tumors received directly from 
C3H animals (2,4). This change in the tumor is permanent and 
can be repeatedly demonstrated after one passage through the 
resistant backcross, (3). 

An indication that the change in host resistence 
following pre-treatment with lyophilized tissue has greater 
applicability than the host-tumor systems usually studied was 
revealed by an increased number of survivals of transplanted 
embryonic tissue and normal spleen in pretreated mice (29). 
Snell (50) viewing the whole field of transplanta¬ 
tion cited the factor of common ancestry as favoring the 
growth of homiotransplants (homiotransplants being defined 
as transplants from one inbred strain to another inbred strain). 
His study of the genetic pattern of transplantation pinpointed 
a ’’histocompatability gene” (H-2 allele) as being the deter¬ 
minate of the success or failure of a transplant (50). 
The enhancing effect is basically immunological 
with the characteristics of (a) specificity, (b) persistency, 
(c) ability to be passively transferred, (d) necessity for 
pretreatment injections to be made before the period of 
active transplant growth (51). 
The nature of the enhancing material in Sarcoma I 
from Strain A mice was delineated by Day, Kaliss and their 
co-workers (16). The enhancing factor was, (a) water extract- 
able and water soluble, (b) unstable above 60° centigrade, 
(c) destroyed by prolonged autolysis or by acid and alkaline 
hydrolysis, (d) either a part of or associated with a 
denaturable high molecular weight protein, (e) in tissues it 

9 
appears to be a constituent of cellular particulates and 
presumably available only in small amounts as a circulating 
humoral factor, 
ACTIVELY ACQUIRED TOLERANCE 
Burnet and Fenner, in their book, ,fThe Production 
of Antibodies”, postulated that antibody production against 
a particular antigen can be specifically suppressed by 
exposure to the same antigen during embryonic life. 
Such an exposure occurs in bovine twin embryos 
because of vascular anastomoses which allow admixture of the 
bloods of the twins (45). As adults these animals do not 
form antibodies to the blood cells of their twin. Experi¬ 
mentally producing an anastomosis between allantochorionic 
vessels of two chicks and then after birth challenging these 
chicks with their partner’s erythrocytes reveals that these 
chicks do not form isoagglutins to the erythrocytes (19). 
Burnet et.al. (8) inoculated chick embryos with 
1) influenza, 2) bacterial viruses, and 3) human red cells 
in an attempt to prove experimentally their postulate. How¬ 
ever, these animals as adults did not differ from control 
animals in their response to the three antigens. 
In a classic work Billingham, Brent and Medawar 
(5) injected six 15 to 16 day old mouse embryos in utero with 
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a ,01 milliliter suspension of tissue from the testes, kid¬ 
ney and spleen of adult A line male mice. The embryos were 
all part of one pregnancy of a CBA female. The injections 
were done at laparotomy and after the injections were com¬ 
pleted the incision was closed and the pregnancy allowed to 
go to term. At that time five animals were born, there 
being no trace of the sixth. At age eight weeks the five 
animals were grafted with adult A line skin. Eleven days 
later two of these grafts were in an advanced stage of break¬ 
down but the other three resembled autografts except for the 
strain specific albinism. Two of these three grafts were 
completely viable at the end of two months. That this was a 
specific reaction to A line skin was demonstrated when skin 
from another line was grafted to the animals with a resultant 
complete breakdown of this latter graft. The hosts ability 
to react to A line tissue had been altered but its reactivity 
to other antigens had not been altered. The initial grafts 
broke down when the hosts were inoculated with chopped lymph 
nodes from normal CBA’s or from CBA’s which had been immunized 
to A line skin (5,6), This proves that the antigenicity of 
the graft had not been impaired but rather that its take was 
dependent on changes in the host’s resistence. The litters 
of these animals did not show any increased tolerance to A 
line skin (5). 
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At the sixteenth to seventeenth day of gestation 
ICR mouse embryos were injected with either (a) blood of 
C3H mice or (b) blood of FI mice from C3H x DBA matings or 
(c) suspension of lymphosarcoma 6C3 which is lethel to C3H 
mice but does not grow in ICR mice. Six to eight weeks 
following birth the animals that had received the blood 
injections in utero were given intraperitoneal injections of 
6C3HED which yielded an ascites tumor in all the animals 
(37). The embryos which received tumor cells had palpable 
tumors ten to 25 days after birth. These embryos were 
incapable of rejecting the tumor which is universally resisted 
by adult mice of the same strain. A suspension of the tumor 
grown in the embryonic mice injected into strains normally 
resistent to this tumor enjoyed a growth comparable to that 
in the indigenous strain. This loss of host specificity is 
similar to that previously noted by Barrett and Deringer (2). 
Koprowski (3$), elaborating on his earlier work, 
injected DBA mouselymphoma into ICR mouse embryos. This tumor 
I i 
does not grow in adult ICR mice but in this study takes of 
75 to 100 per cent were reported in the embryos. This is 
another example of the embryos inability to produce resistence 
to a foreign antigen. 
Wallace (56) was unable to produce tolerance to 
tumors when he injected rat embryos with tissue from the 
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strain that the tumor normally grows in. His injections 
were made on the sixteenth day of gestation, and the tissues 
used were normal cells of spleen, liver, kidney and testes 
suspended in a balanced salt solution. The following 
summarizes Wallace’s results: 
No. with growth 
Tumor Recipient Antigen_ to death of host 
Control Test 
1.C3HBA Wistar C3H cells 0/10 0/20 
2,Sarcoma ISO 
(from C3H mice) Wistar C3H cells 0/9 0/21 
3.dbrB 
(from DBA mice) Wistar DBA cells 0/17 0/16 
4.35FM (from Sprague- 
Dawley rats) 
Hooded Sprague- 
Dawley cells 0/15 0/17 
5.53FM (from Sprague- 
Dawley rats) 
Hooded Sprague- 
Dawley cells 0/15 0/7 
6.53FM (from Sprague- 
Dawley rats) 
Wistar Sprague- 
Dawley cells 0/20 4/18 
Wallace suggests that the use of the same tumor 
for treatment of the embryos and for the adult graft might 
have produced better results. Billingham et. al„, though, 
achieved their success through the use of normal tissue for 
pretreatment. Here again the difference my lie in a species 
specificity or a specificity within a species. The latter 
is suggested by Wallace’s limited success with one host- 
tumor system (53FM tumor-Wistar rats), 
Toolan (55) was also unsuccessful when she tried 
to produce tolerance in rats to human tumors by in utero 
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injections. Her pretreatment material was normal human 
tissue which was obtained from persons other than those who 
yielded the carcinoma. This difference in the antigen and 
the tumor may, in part, explain the failure. 
Felton (16) found that injection of 0,5 milligrams 
of soluble polysaccharide into C3H mice paralyzed the 
animals ability to produce antibody to injected pneumococci. 
The susceptibility of the mouse embryo to treat¬ 
ment with foreign antigen as shown by Billingham et. al, 
raises the question of whether the embryo can be treated 
by ways other than direct injection. The transmission from 
mother to fetus of passive immunity to certain diseases has 
long been recognized. This illustration of the passage of 
antibodies through the placenta has been supplemented by 
work showing that many drugs pass from mother to child in 
utero, e.g. barbiturates, narcotics (18). Studies of 
erythroblastosis fetalis gave rise to the belief that fetal 
red cells pass into the maternal circulation and thus stim¬ 
ulate antibody formation (39). This transplacental transfer 
of red cells was believed to be on a limited scale and due 
to imperfections of the placenta peculiar to this disease. 
That this admixture of blood cells occurs in normal preg¬ 
nancies and through normal placentas was conclusively demon¬ 
strated by Mengert and his group (41). They injected normal 

pregnant women with sickle cells and at birth recovered 
these sickle cells from cord blood. 
In this study it was hoped that by injecting preg¬ 
nant mice with a subcutaneous tumor a change in the reactivity 
of the embryos to that tumor could be elicited. This could 
be accomplished in one of two ways. Firstly, tumor cells 
from the mother might pass to the embryo. If red cells can 
pass through a human placenta it is not too unreasonable to 
hope that tumor cells could pass through the less complex 
mouse placenta. Secondly, the formation by the mother of 
/1 
specific antiserumto the tumor with subsequent transmission 
to the fetus of that antiserum might enhance the growth of 
the tumor in the fetus. The use of such antisera to enhance 
tumor growth has previously been cited in the discussion of 
the work of Kaliss and Molomut (2$), Or, more directly, 
enhancing factor itself might be transmitted through the 
placenta. 

METHODS AND MATERIALS 
This study was divided into two parts. 
PART ONE 
Pregnant mice of Line CB2~j were inoculated sub¬ 
cutaneously in the axillary region with live mouse fibro¬ 
sarcoma 397. This tumor does not grow in CB-j mice. The 
animals in this experiment were two to four months old. The 
tumor was obtained from BC mice carrying the tumor which was 
in its nineteenth to twentyfourth generation. 
The offspring from these pregnancies received sub¬ 
cutaneously in the interscapular area inoculations of tumor 
397 at age eight to nine days. These animals were checked 
for tumor growth four to five times weekly until they were 
six weeks of age. 
PART TWO 
Pregnant animals of the BC-a, BC-b, BC-c and BC-f 
lines were inoculated subcutaneously in the axillary region 
with live mouse fibrosarcoma 397. This tumor grows progress¬ 
ively in these strains producing very large ulcerating lesions 
which do not metastasize but which kill 90 to 100 per cent 
of the mice within four weeks. The mice in this experiment 
were two to four months old. The tumor was obtained from BC 
mice carrying the tumor which was in its 19-24 generation. 
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The offspring from these pregnancies were inocu¬ 
lated subcutaneously in the interscapular area with tumor 
397 within 24 hours of birth. These animals were checked 
for tumor growth four to five times per week. All animals 
were maintained on a prepared diet (Purina Laboratory Chow) 
and water ad libitum. 
BC refers to a group of mice derived by hybridizing 
PM females and C3H males and backcrosses to the PM mice 
followed by brother-to-sister inbreeding. Eleven sublines 
were established and designated by lettering from a to k. 
The mice used in the study have been inbred brother-to-sister 
for more than 25 generations since the original hybridization. 
CB2“j refers to hybrid mice derived by mating BC-j 
females with C57 males. 
Fibrosarcoma 397 is a tumor that arose in a BC30 
female (30 here refers to the number of generations of inbreed¬ 
ing) which starting at age 72 days had received 1.25 milli¬ 
gram weekly of testosterone proprionate. Between day 72 and 
7$ this animal also received x-radiation in three exposures 
of 154r each on alternate days. At death at age 615 days 
this animal had a large sarcoma at the injection site cover¬ 
ing 2x3 centimeters of the lower back. There was a 14x11 
millimeter tumor growth in the liver and numerous smaller 
implants in this organ. The kidneys and spleen were normal. 
The adrenals were large and spotted. Left ovary was 2x3 
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millimeter and there was a possibility that it contained 
tumor. The right ovary was very small. The uterus was 
well developed. The pituitary was normal. 
This tumor which originated in January of 1956 has 
been maintained by passage in BC sublines a, b, c, d, f and 
now (April 1957) is in its twenty seventh generation of 
serial transfer. The tumor does not grow in BC sublines g 
and j. Subcutaneous inoculation of the tumor into susceptible 
animals yields large ulcerating lesions without metastases 
which kill 90 to 100 per cent of the animals within three to 
four weeks. 
In another aspect of this study tissue from human 
uterine myomata was transplanted into the anterior chamber 
of the eyes of mice and guinea pigs (20,42). These animals 
had been inoculated subcutaneously with pellets containing 
diethylstilbestrol (25 per cent) and cholesterol (75 per cent) 
(40). The tissue was obtained at laparotomy and, through the 
cooperation of the surgeons, was removed before the blood 
supply of the uterus was compromised. 
One group of mice received injections of .25 milli¬ 
grams of prednisolone every other day for a period of two 
weeks starting on the day before transplantation. This was 
in addition to the pellets of diethylstilbestrol-cholesterol. 

OBSERVATIONS 
The inoculation of tumor into susceptible BC animals 
within the first 24 hours after birth provoked an extreme 
degree of cannibalism by the mothers. It is conservatively 
estimated that over 100 animals were lost to follow up 
because of this infanticide. Most of the cannibalism occurred 
within 24 hours of the inoculation but the survivors of this 
period were jeopordized again between ten and twelve days of 
age. Only three animals with tumors survived past day 13. 
Therefore, it was apparent that the growth of the tumors had 
to be ascertained at day ten in order to obtain any sort of 
sample. 
All of the BC mothers with tumors bore large 
ulcerating lesions which killed them in three to four weeks. 
There was no evidence of metastases. 
All matings in the study of BC animals were between 
litter mates. 
The tissue from the human uterine myomata was 
obtained from three different patients, all of whom were 
undergoing total abdominal hysterectomy. Though grossly the 
transplants appeared to become vascularized after six or seven 
days in the mice and guinea pigs, histological section of the 
tissue between day 12 to 21 revealed only necrotic tissue 
suggestive of muscle, or fibrous tissue hyperplasia. The 
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latter was interpreted as arising from the host animal in 
response to the foreign body. In the group of mice receiv¬ 
ing cortisone the eyes rapidly became infected and eventually 
became abscesses. There was no trace of the transplants in 
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CBp-j 
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9 days 1/5 
♦Three of these animals had subcutaneous abcesses measuring 
between three and six millimeters in diameter which were 




Growth of Tumor 397 in Mice Born to BC Mothers 
Carrying this Tumor 
Mother 
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BC36b 
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a 1 5 mm 
♦This animal survived to the age of 22 days at which time 
his tumor covered most of the back and measured over 16 
millimeters in length. 
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There was no tumor growth in any of the CB2~j 
mothers. The BC mothers with tumor implants all had 
progressive growth of their tumor and these animals were 
dead within three to four weeks after implantation of the 
tumor. 
The one tumor that grew in an experimental mouse 
of CB2-j parentage was in a black male. This tumor was 
densely adherent to the skin and was bilobar. The animal 
was sacrificed at the age of 22 days (13 days after tumor 
implantation) at which time the two lobes of the tumor 
measured five millimeters and three millimeters in diameter 
respectively. Autopsy failed to reveal any metastases. A 
white female control mouse of CB2-j parentage had a four 
millimeter in diameter subcutaneous tumor when sacrificed at 
22 days of age. There were no metastases. 
There is no statistical difference between the 
rate of growth in the experimental and in the control BC 
mice. The data is summarized in Table II. 

DISCUSSION 
The failure to demonstrate an altered reactivity 
to fibrosarcoma 397 in animals born to mothers who carried 
this tumor subcutaneously may be explained in two parts, 
each part related to one of the hypotheses upon which this 
study was based. 
The first hypothesis was that tumor cells from 
the mother could pass through the placenta into the fetus. 
Koprowski (3$) showed that tumors inoculated into embryos 
would yield progressive growth. However, in this study 
susceptible BC embryos never showed evidence of metastatic 
disease which makes it unlikely that maternal tumor cells 
ever reached the fetus. This possibility cannot be entirely 
ruled out since it has been demonstrated that tumor cells 
free in the peritoneal cavity of humans do not always give 
rise to metastatic growths. 
Fibrosarcoma 397 though a highly vascular tumor 
does not usually metastasize. In retrospect the choice of 
this tumor for the study was an unfortunate one. Even with 
a metastasizing tumor the possibility of tumor cells reach¬ 
ing the placenta would be limited by mechanical factors (15). 




The second hypothesis was that immune sera from 
the mother would pass to the fetus and act as an enhancing 
factor. Another possibility was that enhancing factor 
itself would pass to the fetus. This study would seem to 
indicate that no such thing occurred. 
Fibrosarcoma 397 may not produce an enhancing 
factor in the host animals or in any host. 
One early study suggested that live tumor did not 
contain enhancing factor in useable form and that physical 
alteration, e.g,, freezing, heating, was necessary to elicit 
the enhancing factor (17). No such physical alteration was 
used in this study. However, other studies have successfully 
used live tissue, (35,26). 
Kaliss (35) gave two subcutaneous inoculations of 
live Sarcoma I to resistent C57Bl/6ks mice and found that 
if the inoculations were separated by an interval of greater 
than one month the grafts took while if the interval was 
less than one month the second grafts regressed. None of 
the initial grafts in the study took. In all our own experi¬ 
ments the interval between inoculation of the mother and the 
subsequent inoculation of the offspring was less than a 
month, 
The need in clinical medicine for a method of trans¬ 
planting tissue such as skin or an organ like the kidney has 
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led to many attempts at homotransplantation. With the 
exception of transplants between identical twins or into 
agammaglobulinemic subjects these homotransplants have been 
universally unsuccessful (7,44). The possibility that treat 
ment of a pregnant woman could alter the response of her 
offspring to foreign tissued or organs in such a way that 
the tissued would grow in the offspring is an intriguing one 
The failure of this study to demonstrate such an effect in 
mice with fibrosarcoma 397 should not discourage further 
research along these lines. 

CONCLUSION 
There was no evidence that animals born to mothers 
who had been inoculated with mouse fibrosarcoma 397 had an 
altered reactivity to injection of that tumor. 

SUMMARY 
1. The experimental work relating to the effect 
of altered host resistance to transplants is reviewed under 
the headings of ’’Enhancing Effect” and ’’Acquired Tolerance”. 
2. Pregnant animals of strains both resistant 
and susceptible to mouse fibrosarcoma 397 were inoculated 
with this tumor. The offspring of these pregnant animals 
were inoculated in the neonatal period with fibrosarcoma 397. 
3. There was no difference in the growth of the 
tumor in these offspring as compared to the offspring of 
mothers which had not been inoculated with the tumor. 
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Figure 1: Fibrosarcoma 397 from BC mouse of this study. 
Spindle cells arranged in interesting whorls and strands; 
no necrosis; abundant capillery and sinusoidal blood 
supply; minimal amounts of collagen. Amazingly few 
mitoses for such a rapid growing tumor. H. and E. stain 
(xlOO). 
Figure 2: Fibrosarcoma 397 from first generation transplant 
of this tumor. Many more mitotic figures than that seen 
in later generations of the tumor used in this study. 
Area showing invasion of muscle fibers. H. and E. stain 
(x200). 
Figure 3: Another section from first generation transplant. 
H. and E. stain. 
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